These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36084988)

  • 1. Epidemiology and resource use in Spanish type 2 diabetes patients without previous cardiorenal disease: CaReMe Spain study summary.
    Sicras-Mainar A; Sicras-Navarro A; Palacios B; Sequera M; Blanco J; Hormigo A; Manito N; Alcázar-Arroyo R; Botana-Lopez MA
    Endocrinol Diabetes Nutr (Engl Ed); 2022; 69(7):509-519. PubMed ID: 36084988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and renal diseases in type 2 diabetes patients: 5-year cumulative incidence of the first occurred manifestation and hospitalization cost: a cohort within the French SNDS nationwide claims database.
    Blin P; Joubert M; Jourdain P; Zaoui P; Guiard E; Sakr D; Dureau-Pournin C; Bernard MA; Lassalle R; Thomas-Delecourt F; Bineau S; Moore N; Droz-Perroteau C
    Cardiovasc Diabetol; 2024 Jan; 23(1):22. PubMed ID: 38195491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.
    Norhammar A; Bodegard J; Eriksson JW; Haller H; Linssen GCM; Banerjee A; Karasik A; Mamouris P; Tangri N; Taveira-Gomes T; Maggioni AP; Botana M; Thuresson M; Okami S; Yajima T; Kadowaki T; Birkeland KI;
    Diabetes Obes Metab; 2022 Jul; 24(7):1277-1287. PubMed ID: 35322567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
    Birkeland KI; Bodegard J; Eriksson JW; Norhammar A; Haller H; Linssen GCM; Banerjee A; Thuresson M; Okami S; Garal-Pantaler E; Overbeek J; Mamza JB; Zhang R; Yajima T; Komuro I; Kadowaki T
    Diabetes Obes Metab; 2020 Sep; 22(9):1607-1618. PubMed ID: 32363737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease begets heart failure and vice versa: temporal associations between heart failure events in relation to incident chronic kidney disease in type 2 diabetes.
    Wu MZ; Teng TK; Tay WT; Ren QW; Tromp J; Ouwerkerk W; Chandramouli C; Huang JY; Chan YH; Teramoto K; Yu SY; Lawson C; Li HL; Tse YK; Li XL; Hung D; Tse HF; Lam CSP; Yiu KH
    Diabetes Obes Metab; 2023 Mar; 25(3):707-715. PubMed ID: 36346045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients.
    Ducluzeau PH; Fauchier G; Herbert J; Semaan C; Halimi JM; Angoulvant D; Fauchier L
    Diabetes Metab; 2023 May; 49(3):101429. PubMed ID: 36736892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower heart failure and chronic kidney disease risks associated with sodium-glucose cotransporter-2 inhibitor use in Japanese type 2 diabetes patients without established cardiovascular and renal diseases.
    Komuro I; Kadowaki T; Bodegård J; Thuresson M; Okami S; Yajima T
    Diabetes Obes Metab; 2021 Apr; 23 Suppl 2():19-27. PubMed ID: 33835641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term impact of cardiorenal syndromes on major outcomes based on their chronology: a comprehensive French nationwide cohort study.
    Halimi JM; de Fréminville JB; Gatault P; Bisson A; Gueguen J; Goin N; Sautenet B; Maisons V; Herbert J; Angoulvant D; Fauchier L
    Nephrol Dial Transplant; 2022 Nov; 37(12):2386-2397. PubMed ID: 35438794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal disease manifestation and healthcare resource utilization in patients on first-line oral therapy for type 2 diabetes: A claims-based observational cohort study.
    Olufade T; Jiang L; Israni R; Huang J; Gosmanov AR
    Diabetes Obes Metab; 2021 Dec; 23(12):2741-2751. PubMed ID: 34405521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.
    Nichols GA; Amitay EL; Chatterjee S; Steubl D
    Metab Syndr Relat Disord; 2023 Jun; 21(5):261-266. PubMed ID: 37130317
    [No Abstract]   [Full Text] [Related]  

  • 12. Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.
    Sacre JW; Magliano DJ; Shaw JE
    Diabetes Metab; 2021 Sep; 47(5):101249. PubMed ID: 33744399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower risk of hospitalization for heart failure, kidney disease and death with sodium-glucose co-transporter-2 inhibitors compared with dipeptidyl peptidase-4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care.
    Idris I; Zhang R; Mamza JB; Ford M; Morris T; Banerjee A; Khunti K
    Diabetes Obes Metab; 2021 Oct; 23(10):2207-2214. PubMed ID: 33973690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure.
    Norhammar A; Bodegard J; Vanderheyden M; Tangri N; Karasik A; Maggioni AP; Sveen KA; Taveira-Gomes T; Botana M; Hunziker L; Thuresson M; Banerjee A; Sundström J; Bollmann A
    Heart; 2023 Mar; 109(7):548-556. PubMed ID: 36781285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
    Cherney DZI; Repetto E; Wheeler DC; Arnold SV; MacLachlan S; Hunt PR; Chen H; Vora J; Kosiborod M
    Am J Nephrol; 2020; 51(1):74-82. PubMed ID: 31812955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manifestation of Heart Failure and Chronic Kidney Disease are Associated with Increased Mortality Risk in Early Stages of Type 2 Diabetes Mellitus: Analysis of a Japanese Real-World Hospital Claims Database.
    Kadowaki T; Komuro I; Morita N; Akiyama H; Kidani Y; Yajima T
    Diabetes Ther; 2022 Feb; 13(2):275-286. PubMed ID: 35006534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of multimorbidity on survival of patients diagnosed with heart failure: a retrospective cohort study in Singapore.
    Kaur P; Saxena N; You AX; Wong RCC; Lim CP; Loh SY; George PP
    BMJ Open; 2018 May; 8(5):e021291. PubMed ID: 29780030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both.
    Nguyen C; Luthra R; Kuti E; Willey VJ
    Curr Med Res Opin; 2020 Dec; 36(12):1927-1938. PubMed ID: 33023310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors, outcomes and healthcare utilisation in individuals with multimorbidity including heart failure, chronic kidney disease and type 2 diabetes mellitus: a national electronic health record study.
    Pasea L; Dashtban A; Mizani M; Bhuva A; Morris T; Mamza JB; Banerjee A
    Open Heart; 2023 Sep; 10(2):. PubMed ID: 37758654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials.
    Salah HM; Al'Aref SJ; Khan MS; Al-Hawwas M; Vallurupalli S; Mehta JL; Mounsey JP; Greene SJ; McGuire DK; Lopes RD; Fudim M
    Am Heart J; 2021 Feb; 232():10-22. PubMed ID: 33214130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.